These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23694813)

  • 1. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
    Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR
    Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations.
    Di Leo E; Magnolo L; Bertolotti M; Bourbon M; Carmo Pereira S; Pirisi M; Calandra S; Tarugi P
    Clin Genet; 2008 Sep; 74(3):267-73. PubMed ID: 18492086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B.
    Bonnefont-Rousselot D; Condat B; Sassolas A; Chebel S; Bittar R; Federspiel MC; Cazals-Hatem D; Bruckert E
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):104-8. PubMed ID: 19060634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.
    Di Leo E; Magnolo L; Lancellotti S; Crocè L; Visintin L; Tiribelli C; Bertolini S; Calandra S; Tarugi P
    J Med Genet; 2007 Mar; 44(3):219-24. PubMed ID: 17158591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P; Tanoli T; Wilhelm O; Patterson B; Yablonskiy D; Schonfeld G
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
    Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
    Bataller R; Rombouts K; Altamirano J; Marra F
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
    Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T; Yue P; Yablonskiy D; Schonfeld G
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
    Yilmaz BS; Mungan NO; Di Leo E; Magnolo L; Artuso L; Bernardis I; Tumgor G; Kor D; Tarugi P
    Clin Chim Acta; 2016 Jan; 452():185-90. PubMed ID: 26612772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.
    Zhong S; Magnolo AL; Sundaram M; Zhou H; Yao EF; Di Leo E; Loria P; Wang S; Bamji-Mirza M; Wang L; McKnight CJ; Figeys D; Wang Y; Tarugi P; Yao Z
    J Biol Chem; 2010 Feb; 285(9):6453-64. PubMed ID: 20032471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mutations in APOB100 involved in familial hypobetalipoproteinemia.
    Brusgaard K; Kjaersgaard L; Hansen AB; Husby S
    J Clin Lipidol; 2010; 4(3):181-4. PubMed ID: 21122650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-alcoholic steatohepatitis. Presentation of a case with development into hepatic cirrhosis].
    Valdes Oliveras M; Oristrell Salva J; Allende Monclus E; Bosch Gil JA
    Rev Esp Enferm Apar Dig; 1985 Oct; 68(4):363-5. PubMed ID: 4081262
    [No Abstract]   [Full Text] [Related]  

  • 17. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial ApoB-specific familial hypobetalipoproteinemia in a patient with non-classical congenital adrenal hyperplasia.
    Ramos Bachiller B; Luque-Ramírez M; Rodríguez-Jiménez C; Arrieta Blanco FJ
    Clin Investig Arterioscler; 2024; 36(3):128-132. PubMed ID: 38195282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
    Tarugi P; Averna M; Di Leo E; Cefalù AB; Noto D; Magnolo L; Cattin L; Bertolini S; Calandra S
    Atherosclerosis; 2007 Dec; 195(2):e19-27. PubMed ID: 17570373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.